Applying Scientific Rigor To Microbiome Therapeutics
PharmaBiome’s Second-Generation Candidates
Tomas de Wouters, one of In Vivo’s 2020 Rising Leaders, has taken on the complex challenge of the microbiome, aiming to design the next generation of microbiome therapeutic candidates targeted at host-microbial interactions.